RTB: Terry Michael is adding the numbers this week in this editorial on how to make money in pharmaceuticals.
The toxic balms of Gilead result in sky-rocketing revenues on the eve of the 30th Anniversary of the invention of the “AIDS virus”
Gilead Sciences of Foster City, CA, the politically connected number one dealer of toxic “HIV” anti-retrovirals, celebrated the 30th anniversary of the invention of the AIDS virus a day early, today, April 22, 2014.
The Biblically named company reported 1stQtr2014Revenues of $4,998,956,000 —DOUBLE revenues of $ 2,531,635,000 for the 1st Qtr of 2013. Almost all of the increase came from several new or recent ARV’s, as explained in their press release:
Antiviral product sales increased to $4.51 billion for the first quarter of 2014, up from $2.06 billion for the first quarter of 2013 largely due to sales of Sovaldi® (sofosbuvir 400 mg), which launched in December 2013, and increases in sales of Stribild® (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) and Complera/Eviplera® (emtricitabine 200 mg/rilpivirine 25 mg/tenofovir disoproxil fumarate 300 mg). This increase was partially offset by a decrease in wholesaler and sub-wholesaler inventories in the United States associated primarily with our HIV products, which also impacted antiviral product sales in the first quarter of 2014 compared to the fourth quarter of 2013.
For 2013, Gilead reported ARV revenues of $9.3 billion. If the 1st Qtr 2014 revenue increases are maintained for the rest of the year, Gilead could double its revenue to $18 billion in 2014 (though conditions for the 1st Qtr may have been particularly favorable for sales.)
You will recall that our friend Dr. Tony Fauci, NIAID director-for-life, named Gilead CEO John C. Martin to NIAID’s advisory council way back in March 2000. Gilead’s chairman at the time was Donald Rumsfeld, soon to become George W. Bush’s Secretary of Defense, whose department stockpiled tens of millions of dollars of Gilead’s then big money-maker, TamiFlu, increasingly regarded as worthless, or nearly so. CNN Money.com/Fortune magazine had this revealing story on Rumsfeld, TamiFlu and Gilead’s political connections in 2005. Fauci used Gilead’s “generously donated” Truvada in the bogus, confirmation-biased clinical trial experiments on Third World subjects, which led to Truvada’s fast-tracked (in six months!) FDA approval in 2012 for so-called “pre-exposure prophylaxis”– highly toxic chemotherapy for HIV NEGATIVES.
Gilead’s (GILD) stock prices have zoomed from the low 20s to the low 70s in just the past two years.
The champagne corks should be popping in Foster City, CA Wednesday as the company celebrates the April 23, 1984 invention of the AIDS virus, proclaimed as probably a human retrovirus by HHS Secretary Margaret Heckler in a science-by-press-release media event on that date 30 years ago. It started the money ball rolling for Gilead and the other purveyors of toxic ARV’s.
Happy April 23!